首页 | 本学科首页   官方微博 | 高级检索  
     


Hit selection with false discovery rate control in genome-scale RNAi screens
Authors:Zhang Xiaohua Douglas  Kuan Pei Fen  Ferrer Marc  Shu Xiaohua  Liu Yingxue C  Gates Adam T  Kunapuli Priya  Stec Erica M  Xu Min  Marine Shane D  Holder Daniel J  Strulovici Berta  Heyse Joseph F  Espeseth Amy S
Affiliation:Biometrics Research, Merck Research Laboratories, West Point, PA 19486, USA. Xiaohua_zhang@merck.com
Abstract:RNA interference (RNAi) is a modality in which small double-stranded RNA molecules (siRNAs) designed to lead to the degradation of specific mRNAs are introduced into cells or organisms. siRNA libraries have been developed in which siRNAs targeting virtually every gene in the human genome are designed, synthesized and are presented for introduction into cells by transfection in a microtiter plate array. These siRNAs can then be transfected into cells using high-throughput screening (HTS) methodologies. The goal of RNAi HTS is to identify a set of siRNAs that inhibit or activate defined cellular phenotypes. The commonly used analysis methods including median ± kMAD have issues about error rates in multiple hypothesis testing and plate-wise versus experiment-wise analysis. We propose a methodology based on a Bayesian framework to address these issues. Our approach allows for sharing of information across plates in a plate-wise analysis, which obviates the need for choosing either a plate-wise or experimental-wise analysis. The proposed approach incorporates information from reliable controls to achieve a higher power and a balance between the contribution from the samples and control wells. Our approach provides false discovery rate (FDR) control to address multiple testing issues and it is robust to outliers.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号